Vibativ
NDC Package 62847-002-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vibativ is a medication an antibiotic used to treat serious bacterial infections of the skin and certain types of pneumonia. Marketed by Theravance Biopharma R&d, Inc., this product is identified by NDC 62847-002 and is authorized under FDA application NDA022110.

Identification & Billing

NDC Package Code
62847-002-01
Package Description
1 VIAL, SINGLE-USE in 1 CONTAINER / 17 mL in 1 VIAL, SINGLE-USE
Product Code
62847-002
11-Digit Billing Format
62847000201

Clinical Specifications

Proprietary Name
Vibativ
Dosage Form
-
Usage Information
This medication is an antibiotic used to treat serious bacterial infections of the skin and certain types of pneumonia. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Theravance Biopharma R&d, Inc.
FDA Application #
NDA022110
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-05-2009
End Marketing Date
12-19-2019
Listing Expiration
12-19-2019
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62847-002-01 identifies a specific commercial package of 1 vial, single-use in 1 container / 17 ml in 1 vial, single-use of Vibativ, labeled by Theravance Biopharma R&d, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Theravance Biopharma R&d, Inc. on November 05, 2009. The current certification is valid through December 19, 2019.

What are the primary indications for this medication?

This medication is an antibiotic used to treat serious bacterial infections of the skin and certain types of pneumonia. It works by stopping the growth of bacteria.

How is this Theravance Biopharma R&d, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62847000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62847-002-01
11-Digit CMS (5-4-2)
62847-0002-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.